{"organizations": [], "uuid": "7c0feb0a58da317af2396f238397a73de1dfb31f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pieris-pharmaceuticals-prices-publ/brief-pieris-pharmaceuticals-prices-public-offering-of-5-50-mln-common-shares-at-8-share-idUSASB0C5L3", "country": "US", "domain_rank": 408, "title": "BRIEF-Pieris Pharmaceuticals Prices Public Offering Of 5.50 Mln Common Shares At $8/Share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T07:30:00.000+02:00", "replies_count": 0, "uuid": "7c0feb0a58da317af2396f238397a73de1dfb31f"}, "author": "", "url": "https://www.reuters.com/article/brief-pieris-pharmaceuticals-prices-publ/brief-pieris-pharmaceuticals-prices-public-offering-of-5-50-mln-common-shares-at-8-share-idUSASB0C5L3", "ord_in_thread": 0, "title": "BRIEF-Pieris Pharmaceuticals Prices Public Offering Of 5.50 Mln Common Shares At $8/Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "pieris pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 14, 2018 / 5:31 AM / in 39 minutes BRIEF-Pieris Pharmaceuticals Prices Public Offering Of 5.50 Mln Common Shares At $8/Share Reuters Staff Feb 14 (Reuters) - Pieris Pharmaceuticals Inc: * PIERIS PHARMACEUTICALS ANNOUNCES PRICING OF ITS PUBLIC OFFERING * SAYS PUBLIC OFFERING OF 5.50 MILLION COMMON SHARES PRICED AT $8.00PER SHARE Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )", "external_links": [], "published": "2018-02-14T07:30:00.000+02:00", "crawled": "2018-02-14T08:14:18.003+02:00", "highlightTitle": ""}